— Know what they know.
Not Investment Advice

IPAH OTC

Interpharm Holdings, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -99.8% 1Y: -99.8% 3Y: +0.0% 5Y: -95.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 50 · $660 mcap · 20M float · 0.0000% daily turnover

Cash Flow Trends

Operating Cash Flow
-$14M -1860.9% ▼
Capital Expenditures
$8M -17.1% ▼
5Y CAGR: +132.9%
Free Cash Flow
-$22M -266.5% ▼
Dividends Paid
$124K +50.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$1M -251.4% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2001FY2003FY2004FY2005FY2006
— Operating Activities —
Net Income-$2M$3M-$149K-$4M-$14M
Depreciation & Amort.$160K$886K$1M$2M$3M
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$1M-$4M-$3M$4M-$7M
Other Non-Cash Items$183K$38K-$9K$1M$4M
Operating Cash Flow-$62K$2M-$2M$801K-$14M
— Investing Activities —
Capital Expenditures-$30K-$4M-$8M-$7M-$8M
Acquisitions (Net)$0$0-$1M$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$2M$46K$0$0
Other Investing$0-$160K-$561K-$1M-$293K
Investing Cash Flow-$30K-$3M-$10M-$8M-$8M
— Financing Activities —
Net Debt Issuance-$81K-$2M$9M-$2M$11M
Stock Repurchased$0$0-$8$0$0
Dividends Paid$0$0-$179K-$248K-$124K
Other Financing$0$64K$0-$393K$20K
Financing Cash Flow-$81K$1M$10M$8M$21M
Net Change in Cash-$172K$549K-$2M$902K-$1M
Cash End of Period$1M$3M$536K$1M$72K
Free Cash Flow-$92K-$2M-$10M-$6M-$22M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms